Slides: Targeting risk in patients with CVD, Diabetes or CKD: new guidelines and risk management approaches
Asian Cardio Diabetes Forum 2019
The slides are prepared and presented by the speaker during a PACE-CME educational program. The files are an educational service to registered PACE members only. PACE is not responsible for the content, opinions expressed in the slides
Prof. Deanfield is Professor of Cardiology at University College London (UCL) and Consultant Cardiologist at the Barts Heart Centre (BHC) London UK. He is theDirector of the National Centre for Cardiovascular disease Prevention and Outcomes (NCCPO) at UCL, and Chairman of National Institute for Cardiovascular (CV) Outcomes Research (NICOR) which incorporates the national databases for cardiovascular outcomes.
Prof. Deanfield received CME honoraria and/or consulting fees from Amgen, Boehringer Ingelheim, Merck, Pfizer, Aegerion, Novartis, Sanofi, Takeda, Novo Nordisk, Bayer
Research grants from British Heart Foundation, MRC(UK), NIHR, PHE, MSD, Pfizer, Aegerion, Colgate, Roche - No conflicts of interest for this presentation - Member of SOUL and SELECT Study Steering Committees for Novo Nordisk